This company operates a US FDA-approved topical manufacturing facility, ready to offer a CMO/CDMO model for the US, GCC, EU and ANVISA markets, and is exploring business partners for the distribution and marketing of ANDAs in the US market.

Aucun commentaire disponible.
Laissez votre note & commentaire